Inapure ER 10 Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Ivabradine (10mg)
Overview Inapure ER 10 Tablet
Inapure ER 10 Tablets treat angina pectoris (chest pain stemming from heart problems) and long-term heart failure. It improves cardiac efficiency by reducing heart rate, thus easing chest discomfort and lowering hospitalization risk for heart failure patients. Dosage varies based on the condition being treated. As treatment for angina or heart failure is typically lifelong, cessation requires physician consultation. Administer with food at the same time daily. Overdosage can cause excessive heart rate slowing, breathlessness, and fatigue; seek immediate medical attention if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic alterations. Serious adverse events like syncope and significant heart rhythm changes warrant prompt medical care. Refrain from driving until the medication's effects are known. Avoid Inapure ER 10 Tablets if you have severe hepatic impairment, a slow resting pulse, or a cardiac arrhythmia. It's contraindicated in patients with severely low blood pressure and recently exacerbated heart failure. Interactions may occur with certain antihypertensives, antifungals, and antiretrovirals. Do not use if pregnant, attempting conception, or breastfeeding.
Primary Ingredients of Inapure ER 10 Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Inapure ER 10 Tablet
Managing angina pectoris and heart failure.
Major Benefits of Inapure ER 10 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Inapure ER 10 Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Take this medication with food.
Common Side effects of Inapure ER 10 Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Inapure ER 10 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Inapure ER 10 Tablets should be administered with a meal.
How Inapure ER 10 Tablet works:
Cardiopure Extended Release 10mg tablets decrease cardiac rhythm. This action reduces the heart's oxygen demand, thereby improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Inapure ER 10 Tablet lacks established safety data. Physician consultation is advised.
PregnancyUNSAFE
Using Inapure ER 10 Tablet during pregnancy poses a serious risk. Pregnant women should consult their physician; research in both animal and human studies has revealed substantial adverse effects on fetal development.
Breast feedingUNSAFE
Extended-release Inapure 10 mg tablets are contraindicated for breastfeeding mothers. Available evidence indicates a potential risk of infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Inapure ER 10 Tablet, a medication that can induce transient visual disturbances, primarily phosphenes. Night driving, in particular, should be approached cautiously given the potential for such light flashes.
KidneyCAUTION
Exercise caution when administering Inapure ER 10 Tablets to individuals with severe renal impairment; dosage modification may be necessary. A physician's consultation is advised. Data regarding Inapure ER 10 Tablet use in patients with severe kidney disease is limited.
LiverCAUTION
Patients with liver impairment should use Inapure ER 10 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Inapure ER 10 Tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Inapure ER 10 Tablet :
Omit any missed Inapure ER 10 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Inapure ER 10 Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Sodium channel blockers targeting the sinoatrial node (I<sub>f</sub> current) |



